| Heading: |
Psilocybin |
| Question ID: |
1744374 |
| UIN: |
16066 |
| House: |
Commons |
| Date tabled: |
2024-11-25 |
| Asking Member ID: |
5359 |
| Asking Member display name: |
Neil Duncan-Jordan
|
| Asking Member handle: |
|
| Asking Member Twitter reference: |
Neil Duncan-Jordan
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, if he will take steps to (a) reschedule Psilocybin to allow it to be prescribed and (b) retain its status as a class A substance for other purposes. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2024-11-29 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4444 |
| Answering Member display name: |
Karin Smyth
|
| Answering Member handle: |
karinsmyth
|
| Answering Member Twitter reference: |
@karinsmyth
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
There are no current plans to reschedule psilocybin under the Misuse of Drugs Act 1971, also known as the Act.There is an established process for the development of medicines, overseen by the Medicines and Healthcare products Regulatory Agency (MHRA). Thi... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |